Dotmatics GxP Validation & 21 CFR Part 11 Compliance
Empowering pharmaceutical and life science organizations with cutting-edge AI solutions.
Validation Deliverables for Dotmatics
Validation Master Plan
Overall validation strategy, GAMP 5 category justification, scope, schedule, responsibilities, and risk-based approach. Signed by QA, IT, and scientific owners before any configuration work begins.
URS & Functional Spec
User Requirements Specification in scientist language, Functional Specification mapped to Dotmatics features, and a traceability matrix linking every requirement through test to evidence.
Risk Assessment
ICH Q9(R1) aligned risk assessment for every major Dotmatics module, driving the depth of testing for each requirement. Keeps validation proportional to actual patient-safety risk.
IQ/OQ/PQ Test Scripts
Installation, Operational, and Performance Qualification scripts executed in the qualified environment with documented evidence, deviation handling, and sign-off by QA.
Data Migration Package
Plan, mapping rules, reconciliation approach, and post-migration report with record counts and exception handling — critical for legacy chemistry registry moves.
Validation Summary Report
Final VSR summarizing all validation activity, open items, and formal release for production use. Signed by the quality unit and retained as the primary inspection-ready artifact.
Part 11 and Annex 11 in One Package
We produce a single, integrated validation package that satisfies 21 CFR Part 11 and EU GMP Annex 11 without duplicate testing. Every requirement is traceable from regulation through URS through test evidence to signed-off release.
ALCOA+ as a Design Principle
ALCOA+ is not a checklist applied at the end — it is a design principle for every Dotmatics workflow. Contemporaneous entry, immutable audit trail, enduring retention, and controlled change all feed into configuration decisions on day one. See the MHRA GxP Data Integrity guidance and the FDA Data Integrity guidance.
Scoped to Actual Risk
We never over-validate. ICH Q9(R1) risk-based validation means Category 4 configuration gets appropriate testing and Category 5 custom code gets deeper review — not the other way around. That keeps timelines realistic while still meeting inspection expectations.
Regulatory Frameworks We Cover
FDA 21 CFR Part 11
Electronic records and signatures for pharmaceutical products marketed in the United States. Foundational regulation governing every Dotmatics GxP workflow in-scope for FDA.
Learn moreEU GMP Annex 11
Computerized systems in GMP environments for the European market. Adds explicit risk management, supplier management, incident handling, and periodic review expectations.
Learn moreISPE GAMP 5 Second Edition
Industry-standard framework for risk-based CSV. Published 2022, widely accepted by FDA and EMA inspectors. Sets the structure for all our Dotmatics validation packages.
Learn moreICH Q9(R1) Quality Risk Management
Updated ICH risk management guidance finalized 2023. We use Q9 principles to scope validation effort, set test depth, and justify accepted residual risk.
Learn moreMHRA & WHO Data Integrity
ALCOA+ data integrity expectations from MHRA and WHO. Practical controls on contemporaneous entry, audit trail integrity, and record retention across Dotmatics applications.
Learn moreFDA & EMA AI Guidance
FDA 2025 draft guidance on AI for regulatory decision-making and EMA reflection paper on AI in the medicinal product lifecycle. Applied to any AI agent layered on Dotmatics.
Learn moreOur Validation Approach
We run validation in parallel with implementation, not after it. This is how GAMP 5 Second Edition intends CSV to work in an agile world — risk-driven, incremental, and based on critical thinking rather than rote test execution. The result is faster time to go-live without sacrificing inspection readiness.
Plan Early
Validation Master Plan and category justification produced during discovery — before configuration starts — so scope is agreed upfront with QA.
Test Incrementally
IQ/OQ/PQ execution runs slice-by-slice alongside implementation. Each quarterly capability ships validated, not retrofitted.
Operate Continuously
Periodic review, change control, and incident handling embedded into the operate phase so the validated state is maintained after go-live.
Today's business insights
Profitable growth in the AI solutions industry
Our CEO discusses how AI is transforming the pharmaceutical industry and shares key strategies for leveraging AI in drug discovery and development.
More insights on unlock profitable growth in ai solutions
Inspection Readiness Checklist
Signed VMP & VSR
Validation Master Plan and Validation Summary Report signed by QA, IT, and scientific owners, indexed for rapid retrieval during inspection.
Traceability Matrix
Every requirement traced from URS through functional spec, test case, executed evidence, and final release — no orphan requirements, no untested features.
Executed IQ/OQ/PQ
Test scripts with documented evidence, deviation handling, and sign-offs. Re-tests for any deviations are linked to the original script and re-executed.
Audit Trail Review
Documented evidence that audit trails are reviewed on a defined cadence per Annex 11 and Part 11 — a specific area where inspectors look for SOP adherence.
Periodic Review Log
Current periodic review with change history, incident review, access review, and sign-off. Keeps the validated state current, not just current at go-live.
Supplier Assessment
Documented supplier qualification for Dotmatics, including shared responsibility model for cloud services and current SOC 2 Type II reports on file.
Related Reference Materials
FDA Part 11 Guidance
FDA guidance on Part 11 scope and application, clarifying enforcement discretion and narrowing the set of records strictly subject to Part 11 in practice.
ICH Q10 Pharmaceutical Quality System
ICH Q10 pharmaceutical quality system expectations. Provides the QMS context into which Dotmatics validation fits across the product lifecycle.
ISPE GAMP Data Integrity GPG
ISPE Good Practice Guide on Records and Data Integrity. The reference for implementing ALCOA+ in configured GxP systems including ELN and registration.
PIC/S PI 041
PIC/S guidance on good practices for data management and integrity in regulated environments — used by many non-FDA/EMA inspectorates globally.
WHO Data Management
WHO Technical Report Series 996 Annex 5 — good data and record management practices. International baseline for data integrity expectations.
EMA AI Reflection Paper
EMA reflection paper on the use of AI across the medicinal product lifecycle — foundational reference for validating AI agents on Dotmatics data.
Frequently Asked Questions
Dotmatics applications provide the technical controls required by 21 CFR Part 11 — audit trail, e-signature, access control, record retention — but compliance is a shared responsibility. The vendor validates the platform; you validate your configuration, data, integrations, and SOPs. We deliver the full customer-side validation package under ISPE GAMP 5 (Second Edition) so your Dotmatics deployment is inspection-ready from go-live.
Dotmatics products are typically Category 4 (configured) with Category 5 (custom) elements where you extend with scripts, custom apps, or integrations. Luma configurations, LabArchives templates, and Geneious workflows sit in Category 4; custom API integrations, AI agents, and bespoke Luma apps sit in Category 5. We produce the GAMP 5 category justification as part of the validation master plan so validation effort is proportional — not over-tested on configuration and not under-tested on custom code.
A full Dotmatics validation package contains: Validation Master Plan, User Requirements Specification, Functional Specification, Configuration Specification, Risk Assessment using ICH Q9(R1) principles, Traceability Matrix, IQ/OQ/PQ test scripts with executed evidence, Data Migration Plan and Report, Supplier Assessment, Validation Summary Report, and Periodic Review procedure. All artifacts map to the GAMP 5 framework.
We map every Part 11 requirement — §11.10 controls, §11.30 open systems, §11.50 signature manifestations, §11.70 record/signature linking, §11.100 and §11.200 signature components — to explicit Dotmatics configuration and SOP controls. LabArchives and Luma ELN already support these natively; our job is to configure them correctly, document the mapping, and test that every control works as intended. See the full text of 21 CFR Part 11 and FDA Part 11 Scope and Application guidance.
For EU programs we layer EU GMP Annex 11 on top of Part 11. Key additions include risk management (Annex 11 §1), supplier management (§3.1), incident management (§13), and periodic review (§11). For clinical-scope ELN and assay data we also apply Annex 11 in clinical trials expectations. Our validation approach produces a single integrated package that satisfies both Part 11 and Annex 11 without duplicate work.
We apply ALCOA+ — Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available — to every data flow in the Dotmatics stack. Practical controls include: enforced contemporaneous entry in ELN, immutable audit trails, controlled data migration with reconciliation reports, and period-end record retention checks. See also the FDA Data Integrity and Compliance guidance and the WHO Good Data Management practices.
Yes. Prism is commonly used for regulatory-grade figures in GLP bioanalytical and safety pharmacology. We validate standardized Prism templates, lock down analytical parameters, and prove that specific analyses (for example, four-parameter logistic regression for IC50) return deterministic results. This closes the gap that auditors flag most often — ad-hoc Prism and Excel analyses with no traceable configuration. See the Prism user guide for the analytical primitives we validate.
Validation scope depends on use context. For discovery research, SnapGene and Geneious are typically non-GxP and require only basic qualification. For biologics manufacturing and bioprocess contexts — where sequence data feeds GMP records and regulatory submissions — we validate the specific Geneious Biologics workflows and SnapGene construct traceability paths under GAMP 5 Category 4. We also document the controlled export paths into regulated ELN and registration systems.
AI components are treated as Category 5 under GAMP 5 Second Edition with additional controls — model versioning, prompt versioning, evaluation harness results, drift monitoring, and explicit scope boundaries. We also align with the FDA January 2025 AI draft guidance and with the EMA reflection paper on AI in the medicinal product lifecycle. Our Dotmatics AI integration service ships AI with this validation package included.
Migration into or out of Dotmatics is one of the highest-risk activities in any program. We produce a Data Migration Plan (scope, mapping rules, tolerances, roll-back), run reconciled migration dry-runs in a qualified environment, and produce a Data Migration Report with record counts, checksum comparisons, and exception handling. For legacy chemistry registries, we document canonical structure handling and lineage so that every migrated compound can be traced back to its source registration record.
We establish periodic review per GAMP 5 Appendix O8, typically annual for ELN and registration, and semi-annual for high-risk integrations or AI components. Each review covers change history, incident review, access review, evaluation metric review (for AI), training status, and SOP alignment. Findings feed into the next quarterly release. See also the PDA CSV primer for background on periodic review expectations.
We produce a Supplier Assessment for Dotmatics as part of the validation package, covering the vendor quality management system, SOC 2 Type II reports, penetration testing posture, and incident response. This aligns with ISPE GAMP Good Practice Guide on IT Infrastructure and with ICH Q10 pharmaceutical quality system expectations. For hosted Dotmatics cloud services we also document the shared responsibility model so it is clear which controls the vendor provides and which remain your responsibility.
Get Your Dotmatics Deployment Inspection-Ready
Full GAMP 5 validation for Luma, LabArchives, Prism, SnapGene, Geneious, and IDBS. See also Dotmatics services and AI integration.
Book a Meeting